Brainomix Achieves Breakthrough with FDA Clearance of e-Lung AI Software
Published on 08/07/2025 at 18:08 | prnewswire.co.uk
Established market leader in stroke AI imaging receives its first FDA clearance in the lung imaging space.With this expanded foundation of AI-driven healthcare solutions, the Oxford-based company remains committed to driving innovation and delivering impactful advancements in imaging biomarkers.
M +44 (0)7968 726585
M +44 (0)7968 726585
Logo - https://mma.prnewswire.com/media/1989193/3856380/Brainomix_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/brainomix-achieves-breakthrough-with-fda-clearance-of-e-lung-ai-software-302144836.html
en | boerse | 67932902 |
